Table 2.
Year | Tissue/Cell Type | N | miRNA | Reference |
---|---|---|---|---|
2021 | SW626, SKOV3, OVACAR3, PA1 | N/A | miR-101 | Wei et al. [47] |
2020 | A2780cp, A2780s, SKOV3, CAOV3 | N/A | miR-193b | Li et al. [51] |
2020 | Tumour & TAN | 45 | miR-27b-5p | Liu et al. [50] |
2020 | Tumour & TAN | 31 | miR-584 | Yang et al. [49] |
2020 | SKOV3 | N/A | miR-155-5p | Ysrafil et al. [52] |
2018 | Blood, OVCAR3 | 8 | miR-195 | Chen [53] |
2016 | Tumour, SKOV3, OVCAR-429 | 20 | miR-125a, miR-125b | Lee et al. [54] |
2019 | Tumour & TAN, serum, OVAR3, HEY-A8 | 17 | let-7g | Biamonte et al. [55] |
2021 | Tumour & TAN, SKOV3, A2780 | 10 | miR-585-3p | Lu et al. [56] |
2021 | Serum | 30 | miR-193a-5p | Zhang et al. [57] |
N = number of tissue samples, TAN = tumour-associated normal.